The advanced wound care market in the Middle East is showing stable growth, primarily driven by the increasing number of chronic wound cases, particularly DFU. Data indicates that the advanced wound care market in the Middle East is expected to reach USD 4.8 billion by 2028, with a compound annual growth rate (CAGR) of 5.8%....Read More
Oneness Listed in the S&P Global Sustainability Yearbook for the Third Consecutive Year, Ranking Among the Top 10 in the Global "Pharmaceuticals Industry" for 2025Read More
Oneness has received notification from the Notified Body, confirming that we comply with the MDSAP (Medical Device Single Audit Program) quality management system standards. The MDSAP certificate has been issued with the certificate number: MDSAP 803792Read More
Oneness Biotech Co., Ltd., had been granted with MDSAP (Medical Device Single Audit Program) certification for medical device quality management system.Read More
According to the International Diabetes Federation (IDF), the population of Saudi diabetic patients are more than 4 million people. The number of DFU patients is approximately 500,000. Current treatments in Saudi Arabia are mostly traditional remedies, and the incidences of ulcer infection and amputation are relatively high.Read More
U.S. FDA notified Oneness today that Bonvadis® for partial thickness wounds, closed post-surgical wounds, and burns (1st and superficial 2nd degrees) is 510(k) cleared.Read More
